Atara Biotherapeutics Stock Rises 14% On Swing To Profit In Q1

(RTTNews) - Atara Biotherapeutics, Inc. (ATRA) shares jumped 14.45 percent to $7.57 on Thursday, gaining $0.95 after the company reported a strong turnaround in its first-quarter results.

The company posted net income of $38.0 million, or $3.53 per share, compared to a net loss of $31.8 million, or $5.65 per share, in the same period last year. Total revenues surged to $98.1 million from $27.4 million year over year.

The stock opened at $7.49 and traded between $7.02 and $7.99 on the Nasdaq. Volume reached 128,035 shares, more than double its average of 57,391. Atara is currently trading above its 52-week low of $5.01 and well below its high of $18.70.